At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Ascending
Jul 11, 2008 bloch stephen m Director Automatic Sell 8,893 12.55
Oct 13, 2008 bloch stephen m Director Automatic Sell 3,000 12.58 - 13.75
Jul 14, 2008 bloch stephen m Director Automatic Sell 1,600 12.61
Jul 15, 2008 bloch stephen m Director Automatic Sell 5,600 12.90
Jul 15, 2008 licholai gregory p Officer Sell 15,000 13.00
Jul 16, 2008 bloch stephen m Director Automatic Sell 1,900 13.16
Jul 17, 2008 bloch stephen m Director Automatic Sell 1,600 13.38
Aug 22, 2008 bloch stephen m Director Automatic Sell 3,000 13.52
Aug 20, 2008 patterson matthew r Officer Automatic Sell 2,000 13.54
Aug 19, 2008 bloch stephen m Director Automatic Sell 3,000 13.56
Aug 21, 2008 bloch stephen m Director Automatic Sell 3,000 13.57
Aug 26, 2008 crowley john f Officer Sell 13,333 13.61
Aug 26, 2008 bloch stephen m Director Automatic Sell 4,200 13.64
Aug 25, 2008 bloch stephen m Director Automatic Sell 3,000 13.67
Aug 19, 2008 patterson matthew r Officer Automatic Sell 4,500 13.71 - 14.50
Aug 20, 2008 bloch stephen m Director Automatic Sell 3,000 13.72
Sep 3, 2008 bloch stephen m Director Automatic Sell 3,000 13.72
Sep 5, 2008 crowley john f Officer Automatic Sell 2,500 13.74 - 13.74
Sep 3, 2008 crowley john f Officer Automatic Sell 2,500 13.75 - 13.79
Sep 2, 2008 crowley john f Officer Automatic Sell 2,600 13.75 - 13.82
Showing 301-320 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy